SYBX
Price:
$1.15
Market Cap:
$13.45M
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratum...[Read more]
Industry
Biotechnology
IPO Date
2015-09-30
Stock Exchange
NASDAQ
Ticker
SYBX
According to Synlogic, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.65. This represents a change of -16.86% compared to the average of 3.19 of the last 4 quarters.
The mean historical Current Ratio of Synlogic, Inc. over the last ten years is 11.37. The current 2.65 Current Ratio has changed 2.23% with respect to the historical average. Over the past ten years (40 quarters), SYBX's Current Ratio was at its highest in in the June 2017 quarter at 33.83. The Current Ratio was at its lowest in in the December 2023 quarter at 2.45.
Average
11.37
Median
12.83
Minimum
2.45
Maximum
22.23
Discovering the peaks and valleys of Synlogic, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 298.70%
Maximum Annual Current Ratio = 22.23
Minimum Annual Increase = -62.84%
Minimum Annual Current Ratio = 2.45
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 2.80 | 14.28% |
| 2023 | 2.45 | -62.84% |
| 2022 | 6.58 | -51.44% |
| 2021 | 13.55 | 12.02% |
| 2020 | 12.10 | -15.60% |
| 2019 | 14.34 | -2.56% |
| 2018 | 14.71 | 52.63% |
| 2017 | 9.64 | -56.63% |
| 2016 | 22.23 | 44.89% |
| 2015 | 15.34 | 298.70% |
The current Current Ratio of Synlogic, Inc. (SYBX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.94
5-year avg
7.50
10-year avg
11.37
Synlogic, Inc.’s Current Ratio is greater than Lixte Biotechnology Holdings, Inc. (1.84), greater than Allarity Therapeutics, Inc. (2.33), less than Lexaria Bioscience Corp. (3.90), greater than Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (0.27), greater than Cingulate Inc. (1.26), greater than Curis, Inc. (0.70), greater than Entero Therapeutics, Inc. (2.62), less than Kairos Pharma, Ltd. (16.56), less than BriaCell Therapeutics Corp. (3.41), less than Processa Pharmaceuticals, Inc. (3.45),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.84 | $19.34M | |
| 2.33 | $16.85M | |
| 3.90 | $20.27M | |
| 0.27 | $13.21M | |
| 1.26 | $22.09M | |
| 0.70 | $17.45M | |
| 2.62 | $11.06M | |
| 16.56 | $18.86M | |
| 3.41 | $23.06M | |
| 3.45 | $15.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synlogic, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Synlogic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Synlogic, Inc.'s Current Ratio?
How is the Current Ratio calculated for Synlogic, Inc. (SYBX)?
What is the highest Current Ratio for Synlogic, Inc. (SYBX)?
What is the 3-year average Current Ratio for Synlogic, Inc. (SYBX)?
What is the 5-year average Current Ratio for Synlogic, Inc. (SYBX)?
How does the current Current Ratio for Synlogic, Inc. (SYBX) compare to its historical average?